(Q69535480)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2673794%20AND%20SRC:MED&resulttype=core&format=json

3 October 2019

title

Relevance of genetic polymorphism in drug metabolism in the development of new drugs (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2673794%20AND%20SRC:MED&resulttype=core&format=json

3 October 2019

author name string

L P Balant

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2673794%20AND%20SRC:MED&resulttype=core&format=json

3 October 2019

U Gundert-Remy

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2673794%20AND%20SRC:MED&resulttype=core&format=json

3 October 2019

A R Boobis

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2673794%20AND%20SRC:MED&resulttype=core&format=json

3 October 2019

C von Bahr

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2673794%20AND%20SRC:MED&resulttype=core&format=json

3 October 2019

publication date

1 January 1989

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2673794%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Clinical Pharmacology

3 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2673794%20AND%20SRC:MED&resulttype=core&format=json

3 October 2019

volume

36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2673794%20AND%20SRC:MED&resulttype=core&format=json

3 October 2019

page(s)

551-554

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2673794%20AND%20SRC:MED&resulttype=core&format=json

3 October 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2673794%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00637734

3 October 2019

exact match

0 references

cites work

The polymorphic oxidation of beta-adrenoceptor antagonists. Clinical pharmacokinetic considerations

1 reference

12 December 2020

Defective oxidation of drugs: pharmacokinetic and therapeutic implications

1 reference

12 December 2020

Hepatic monooxygenase activities in subjects with a genetic defect in drug oxidation.

1 reference

12 December 2020

Premarketing observational studies of population pharmacokinetics of new drugs

1 reference

12 December 2020

Effect of oxidative polymorphism (debrisoquine/sparteine type) on hepatic first-pass metabolism of bufuralol

1 reference

12 December 2020

Drug metabolism in human liver in vitro: establishment of a human liver bank.

1 reference

12 December 2020

Quinidine: potent inhibition of sparteine and debrisoquine oxidation in vivo.

1 reference

12 December 2020

A family and population study of the genetic polymorphism of debrisoquine oxidation in a white British population.

1 reference

12 December 2020

Monooxygenase activity of human liver in microsomal fractions of needle biopsy specimens

1 reference

12 December 2020

Quinidine and the identification of drugs whose elimination is impaired in subjects classified as poor metabolizers of debrisoquine

1 reference

12 December 2020

Steady-state levels of imipramine and its metabolites: significance of dose-dependent kinetics

1 reference

12 December 2020